Posts Tagged ‘Depression’

Tianeptine – An Alternative Worse Than Opioids

Monday, March 15th, 2021

Just when one might have thought that the U.S. was getting a handle on opioid addiction, another harmful and highly addictive opioid-like drug has appeared in widespread use.

The March 2021 issue of Consumer Reports has a comprehensive article about Tianeptine, an illegal drug linked to reports of harm, abuse and deaths.

Tianeptine acts in the brain as an opioid. The FDA says it is illegal and unsafe in the U.S., although it is approved as a prescription antidepressant in some European, Asian, and Latin American countries.

Reports indicate that tianeptine is even more addictive, with more severe withdrawal adverse reactions, than opioids and heroin.

Yet some proponents, possibly motivated by greed if not by malign intentions, are trying to get the FDA to approve it as a prescription drug for depression in the U.S.

Are You Depressed?

Psychiatry is heavily pushing false data about depression.

The fact is, the American Psychiatric Association, the American Medical Association and the National Institute of Mental Health admit that there are no medical tests to confirm mental disorders as a disease but do nothing to counter the false idea that these are biological/medical conditions when in fact, diagnosis is simply done by a checklist of behaviors.

People do experience symptoms of depression. But there are non-harmful, medical alternatives; addictive and harmful psychiatric drugs are not the solution.

Deja Poo - The feeling that you've heard this crap before.
deja poo

Magnetic Seizure Therapy – How Unattractive!

Monday, December 14th, 2020

In 1993 a team of researchers from the United States and Switzerland triggered seizures in patients with a magnetic field. They thought this was wonderful, and could lead to a revolution in treatment of various ailments.

Yet competent medical experts warn that seizures are linked to developmental disabilities, learning and behavioral disorders, and many other negative long-term outcomes. The Mayo Clinic advises people to seek immediate medical help if one has a seizure.

Psychiatrists, however, are banking on making a ton of money by forcing vulnerable people to have seizures for depression.

Magnetic Seizure Therapy (MST) is a brain stimulation therapy in which magnetic pulses deliberately induce seizures, similar to electroconvulsive therapy (ECT), in patients under general anesthesia.

Like Repetitive Transcranial Magnetic Stimulation (rTMS), MST uses magnetic pulses instead of electricity to restimulate a precise target in the brain. However, unlike rTMS, MST aims to induce a seizure like ECT does, in the forlorn hope that this would not have all the horrific side effects of ECT.

The claim is that this assault on the brain reduces symptoms from major depression or bipolar disorder in 30-40% of individuals so treated. Well, of course it might temporarily reduce symptoms, since it basically shuts down normal activity of the brain for a period.

Unfortunately, it doesn’t cure anything and never will, while also carrying the significant risks of anesthesia exposure and induction of seizures.

Even the psychiatric billing bible, the Diagnostic and Statistical Manual of Mental Disorders (DSM), carries a category for seizures [“Conversion disorder (functional neurological symptom disorder), With attacks or seizures”], for which psychiatrists can prescribe one or more psychotropic drugs. [A Conversion Disorder is a mental condition in which a person has some neurologic symptoms unrelated to a specific disease.]

All competent medical personnel know about the grave consequences of untreated seizures, yet psychiatrists actually promote this as a “treatment.” How do they get away with this?

Seizures are also one of the possible adverse side effects of various psychiatric drugs such as psychostimulants, antidepressants, antipsychotics, anti-anxiety drugs, and lithium. What’s one more so-called “treatment” that causes seizures?

The psychiatric industry has a history of deliberately reducing their patient’s intelligence as a “treatment.” Evidence that electroshock lowers IQ is certainly available. Documented side effects of ECT include lowered intellectual function, with a 20- to 40-point drop in IQ.

Are you beginning to see the pattern here? Since psychiatry cannot cure any mental disorder, they turn to “treatments” which just knock you out so you don’t feel bad any more. Of course, you don’t feel good, either.

Sure, fry your brain with magnetic seizure therapy! Who knows, it may enhance your natural animal magnetism (Not!).

Traumatic Brain Injury

How psychiatry Usurps Climate Change Planning

Monday, August 17th, 2020

Reference:
United Nations Promoting Sustainable Development
Resolution adopted by the United Nations General Assembly on 25 September 2015 “Transforming our world: the 2030 Agenda for Sustainable Development

Sustainable: Of, relating to, or being a method or lifestyle for using resources so that the resources can be maintained and continued, and are not depleted or permanently damaged.

[from Old French sustenir (French: soutenir), from Latin sustineo, sustinere, from sub– (under) + teneo (hold, uphold, possess, guard, maintain)]

The U.N. Sustainable Development Goals

The 17 United Nations Sustainable Development Goals (SDG) and their 169 associated targets adopted in 2015 and accepted by all Member States seek to realize the human rights of all and balance economic, social and environmental factors towards peace and prosperity for all.

To this end we examine some of the existing factors which block or inhibit the realization of these goals, and which must be eliminated so that the goals can be achieved in practice.

SDG 13Take urgent action to combat climate change and its impacts.
Target 13.2: Integrate climate change measures into national policies, strategies and planning.

How Psychiatry Obstructs Target 13.2
The psycho-pharmaceutical industry has jumped full-time onto the climate change bandwagon. Scholarly articles are being published claiming that climate change affects mental health, along with the typical cries to fund more research, prescribe more antidepressants, and prepare for the worst.

The Diagnostic and Statistical Manual of Mental Disorders (DSM) does not lack for possible disorders that can be tied to some climate change disaster for which antidepressants can be prescribed.

It used to be called “Seasonal Affective Disorder” (SAD). Although this is no longer classified as a unique disorder, it can still be diagnosed as a “mood disorder with a seasonal pattern.” SAD is considered a subtype of major depression or bipolar disorder. An example of a SAD diagnosis might be “Major Depressive Disorder, Recurrent Episode, Moderate, With Seasonal Pattern”.

Here we have the “dangerous environment” in full bloom. Wherever psychiatry intervenes, the environment becomes more dangerous, more unsettled, more disturbed. A dangerous environment only persists if we fail to spread a safe environment across the world. What makes a dangerous environment? Confusion, conflict and upset.

The psychiatrists who promote a dangerous environment make it seem as threatening as possible so that they can profit from it. How do you counter this? You stop spreading the chaos and spread the truth instead. Behind the truth comes the calm. You may still need technology to handle climate change, but you don’t need antidepressant drugs to do so.

The issue is not “is there or is there not climate change?” The issue is, get rid of the psychiatrists who are promoting and profiting from the confusion.

Psychiatric fraud and abuse must be eradicated so that SDG 13 can occur.

Climate Change

Scientists Gave Ketamine to Sheep and were Baaaffled by the Result

Sunday, July 5th, 2020

“While studying the effects of ketamine on sheep, researchers say they found something truly strange: high doses of the drug appeared to turn the sheep’s brains off…”

First, why were they abusing sheep?

Second, we already know that ketamine is abusive to people.

And finally, we already know that ketamine, a powerful psychedelic anesthetic, is being relentlessly touted as a “new antidepressant” when in fact it just knocks you out so you don’t feel much of anything, a surefire clue that the brain has been turned off.

The same applies to Spravato (Esketamine), a nasal spray version of the anesthetic drug.

Ketamine is also known to be an illicit party drug, used by rapists to quell their victim’s movements. It’s hard to imagine how this “Club Drug” could be hailed by some psychiatrists as a potential solution for suicidal patients.

The use of ketamine to treat so-called depression is unethical and actually harmful, since it precludes the patient from finding out what is actually wrong and getting that treated. Psychiatrists pushing ketamine or esketamine are shameful drug pushers who are making a buck off people’s misfortune.

Click here for the truth they don’t want you to know about ketamine.

Ketamine for everything

Psychiatrists Anxious to Treat All Child-bearing Women for Post-Partum Depression

Saturday, June 15th, 2019

The FDA approved the first drug treatment for post-partum depression (PPD) on March 19, 2019. Psychiatrists call this “peripartum depression”, which means depressive symptoms during pregnancy or after childbirth. While there is no  actual diagnostic test for this, the current revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) labels this with various alternative wordings of “depressive disorder” or “bipolar disorder” or “anxiety disorder” or “stress disorder,” sometimes with the specifier “with peripartum onset“, depending on the circumstances.

The diagnosis is totally subjective, and is a justification for making money for prescribing an antidepressant. Psychiatrists do not typically perform any clinical tests to find out if there is a real medical reason for the symptoms, such as thyroid problems or vitamin deficiencies. Research suggests that rapid changes in hormones and thyroid levels during and after delivery have a strong effect on moods, yet this is mostly ignored by the psychiatric industry since it is easier and more profitable to prescribe a psychotropic drug.

The drug is Zulresso (generic brexanolone), an intravenous infusion administered continuously over 60 hours (2.5 days) and requiring constant monitoring. There is a risk of serious harm due to a sudden loss of consciousness during the treatment, the appearance of suicidal thoughts and behaviors, or hypoxia (loss of oxygen in the blood). The drug passes into breast milk, but there is no data on the safety of brexanolone while breastfeeding. The cost has currently been set at $34,000 per course of treatment.

Sage Therapeutics says that this neurosteroid, a derivative of allopregnanolone, affects GABAA (Type-A gamma-Aminobutyric acid) neurotransmitter receptors in the brain, although the actual mechanism of action of this drug with respect to PPD (or any other condition) is unknown.

Many people think that post-partum depression is a mental illness. However, this is very misleading for a mother who has experienced the trauma of just giving birth. To have them think the emotional roller coaster they may be experiencing is the result of a “chemical imbalance in the brain,” requiring mind-altering medication, is false and potentially very harmful.

This does not mean that serious emotional difficulties do not exist. But it does mean that psychiatrists and psychologists have used such difficulties to their advantage, promoting powerful drugs as a “solution” for vulnerable individuals. This has been for the sake of profit, often at the expense of people’s lives.

Quite apart from such drugs causing harm, they are also unnecessary. Any competent medical doctor who takes the time to conduct a thorough physical examination of someone exhibiting signs of what psychiatrists say are “mental disorders,” including post-partum depression, can find undiagnosed, untreated physical conditions.

Instead, psychiatrists prefer to tell young mothers that their condition is an “illness,” requiring “medication,” potentially endangering the life of the mother and her child.

Women may experience drastic drops in hormone levels after the birth of a child that can deliver a major shock to the woman’s body. Nutritional and mineral depletion or deficiencies as well as a lack of sleep while caring for a baby can also cause the symptoms psychiatrists say are a “mental disorder.” It can be treated nutritionally.

For more information, download and read the CCHR bookletThe Drugging of ‘Post Partum Depression’ – Clearing up Misconceptions About ‘Chemical Imbalances,’ Antidepressant Drugs and Non-Drug Solutions“.

Set It and Forget It Birth Control

Tuesday, May 21st, 2019

We’ve recently been seeing frequent TV ads for Kyleena and Mirena, intrauterine devices (IUDs) that slowly release a progestin hormone called levonorgestrel into the uterus to prevent pregnancy, sometimes referred to as “Set it and forget it birth control.”

Interestingly enough, the manufacturer of levonorgestrel tablet contraceptives (Plan B) says “This medication is an emergency contraceptive and should not be used as a regular form of birth control.”

Possible adverse side effects from these IUD devices include ovarian cysts, abdominal/pelvic pain, headache or migraine, acne, breast tenderness or pain, heavier bleeding, depression, changes in hair growth, and hair loss.

The potential for depression as a side effect caught our attention.

Then the May 2019 Scientific American was published with several articles about birth control, indicating that the occurrence of bad side effects from IUDs are much higher than one might suspect.

One article brought it even closer to our home, saying that “Much of the recent enthusiasm over IUDs can be traced back to a single study called the Contraceptive CHOICE research project [2007-2011]. Funded in part by a then anonymous donor now known to be the Susan Thompson Buffett Foundation and facilitated by Washington University in St. Louis, the project had the explicit goal of increasing the use of LARC [Long-Acting Reversible Contraception] among women at high risk of unintended pregnancy.”

Obviously we are not advocating for or against anything related to birth control; our sole interest is in how the psychiatric industry may be involved. And with depression as a side effect of these devices, we have a clue.

We’ve all heard the term Premenstrual Syndrome (PMS), which includes symptoms such as mood swings, irritability and depression. Current thinking is that over 90% of women get some PMS adverse side effects.

Naturally, if psychiatrists can prescribe a drug for it, they will include it in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) so that insurance will pay for diagnosing it and prescribing a drug.

So what does the DSM have to say about it? Here are some possible related diagnoses:

— Premenstrual dysphoric disorder [dysphoric means “a state of unease or dissatisfaction”]
— Problems related to unwanted pregnancy
— Depressive disorder due to another medical condition
— Unspecified depressive disorder
plus another 75 disorders related to depression of one kind or another.

All of these fraudulent diagnoses can be used to prescribe an antidepressant or some other harmful and addictive psychiatric drug, none of which actually address the root cause of the condition.

Need we actually say that premenstrual dysphoric disorder, or PMS, is not a “mental illness” requiring an antidepressant? Need we actually say that a depressive side effect of an IUD is not a “mental illness” requiring an antidepressant?

Well, we’ve said it anyway. Protect yourself from psychiatric fraud and abuse by insisting on Full Informed Consent with your doctor.

Knock Yourself Out with Spravato (Esketamine)

Monday, March 18th, 2019

A nasal spray version of the anesthetic drug ketamine was approved by the FDA on March 5, 2019 for treatment-resistant depression.

Janssen Pharmaceuticals says that the cost for a one-month course of treatment for Spravato (generic esketamine) will be between $4,720 and $6,785.

Esketamine is the S-enantiomer of ketamine, which means that it is one of the two mirror images of the chemical structure of ketamine, S (for the Latin sinister) being the left image. It enhances glutamine release in the brain. Glutamine is an amino acid used in the synthesis of proteins, among other things. In the brain, glutamine is used in the production of neurotransmitters. It is believed that glutamine plays a role in raising or lowering aggression levels.

Treatment requires that doses be taken, in conjunction with an oral antidepressant, in a doctor’s office or clinic, with patients monitored for at least two hours, and their experience entered in a registry.

Because of the risk of serious adverse outcomes and the potential for abuse and misuse of the drug, it is only available through a restricted distribution system. At least you can’t take it home with you.

The Spravato labeling contains a Boxed Warning that cautions that patients are at risk for sedation and difficulty with attention, judgment and thinking (dissociation), abuse and misuse, and suicidal thoughts and behaviors after administration of the drug.

Basically, it knocks you out so you don’t feel so depressed anymore. You don’t feel much of anything, actually, since you’ve just taken an anesthetic in the snout.

There were four phase 3 clinical trials; two of them failed to show any statistical improvement, but the drug was approved anyway because it was on the Fast Track and Breakthrough Therapy paths.

A 9/5/2018 update from Consumer Reports said, “All these drugs [Ketamine, Phenylbutazone, Chloramphenicol] are prohibited in beef, poultry, and pork consumed in the U.S. Yet government data obtained by Consumer Reports suggest that trace amounts of these and other banned or severely restricted drugs may appear in the U.S. meat supply more often than was previously known.”

Note that “depression” is not an actual medical illness; it is simply a symptom of some undiagnosed and untreated condition. A diagnosis of depression is a prime example of psychiatric fraud.

Any form of ketamine used to treat so-called depression is unethical and harmful, since it precludes the patient from finding out what is actually wrong and getting that treated. Psychiatrists pushing ketamine or esketamine are shameful drug pushers who are making a buck off people’s misfortune.

Go here for more information about alternatives to drugs.

Depression and The Marketing of Madness

Sunday, March 10th, 2019

The high-income partnership between psychiatry and drug companies has created an $80 billion psychotropic drug profit center, requiring constant marketing to push harmful and addictive psychotropic drugs on a vulnerable public.

How did psychotropic drugs, with no target illness, no known curative powers and a long and extensive list of harmful side effects, become the go-to treatment for every kind of psychological distress? And how did the psychiatrists espousing these drugs come to dominate the field of mental treatment?

Clever marketing hides the harm in a succession of consumer ads constantly churning through “new revelations.”

The most recent we’ve seen have been these gems:

— A new marketing catchphrase is being used in a Trintellix commercial — “Depression is multiple symptoms.”

— Another new marketing catchphrase is being used in a Latuda commercial — “A different type of depression.”

Psychiatry continues heavily pushing false data about depression

The fact is, the American Psychiatric Association, the American Medical Association and the National Institute of Mental Health admit that there are no medical tests to confirm depression as a disease but do nothing to counter the false idea that these are biological/medical conditions when in fact, diagnosis is simply done by a checklist of behaviors.

There are 77 entries in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) using some variation of the word “depressive”, so that nearly anyone can be so diagnosed and prescribed harmful and addictive psychotropic drugs.

Yes, people experience various symptoms of mental distress. This does not make them “mentally diseased” and there is no evidence of physical/medical abnormality for the so-called diagnosis of “depression.” This doesn’t mean that there aren’t solutions for people experiencing difficulty; there are non harmful, medical alternatives. But they do not require a psychiatric “label” to treat them. There is no mental illness test that is scientifically/medically proven. This isn’t a matter of opinion — psychiatrists who are opposed to the labeling of behaviors as mental illness openly admit this.

Dr. Thomas Szasz said, “The term ‘mental illness’ refers to the undesirable thoughts, feelings, and behaviors of persons.” More properly, it is just what psychiatry and psychiatrists have inappropriately labeled as “undesirable behavior;” the prime undesirable antisocial people on the planet telling you what they think is undesirable!

Find out more about the fake “disease” called depression and the harm that anti-depressive drugs do.

Watch the documentary exposing the truth behind the slick marketing schemes and scientific deceit that conceal a dangerous and often deadly sales campaign.

The Marketing of Madness Education Package is the ultimate resource for educating others on the dangerous effects of psychotropic drugs, and the multi-billion-dollar psychiatric-pharmaceutical partnership now dominating the field of mental health. CCHR is offering this kit for free to educators and lecturers to assist them in educating others about the risks of these mind-altering drugs, and to furnish information that is generally not told to patients or physicians. Arm yourself with the facts about psychiatry.

Orilissa May Cause Suicidal Ideation

Monday, February 18th, 2019

Orilissa (generic elagolix) is a drug from AbbVie Inc. and Neurocrine Biosciences, approved by the FDA in the summer of 2018, and prescribed for women with moderate to severe endometriosis pain. Endometriosis is a chronic disease in which uterine lining tissue grows outside the uterus. The drug shuts down the hormonal cycle, stopping the monthly menstrual period. It is currently being heavily advertised, with a list price of approximately $850 per month.

It caught our attention because some of the serious side effects are suicidal thoughts, actions, or behavior, and worsening of mood.

The prescribing information advises that patients with new or worsening depression, anxiety or other mood changes should be referred to a mental health professional. We urge caution, because a psychiatrist may misdiagnose such symptoms as a mental disorder rather than a drug side effect, and prescribe harmful psychotropic drugs instead of properly handling the side effects.

Suicidal ideation and behavior, including one completed suicide, occurred in subjects treated with Orilissa in the endometriosis clinical trials. Users had a higher incidence of depression and mood changes compared to placebo. Some of the most common adverse reactions in clinical trials included anxiety, depression and mood changes.

The drug is a gonadotropin-releasing hormone antagonist, which means it blocks the receptors of certain hormones in the brain’s pituitary gland, leading to the suppression of luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone. Patients are advised to limit the duration of use because of bone loss; bone mineral density loss is greater with increasing duration of use and may not be completely reversible.

The drug is metabolized in the liver by cytochrome P450 enzymes, so a person genetically deficient in these enzymes, or who is taking other drugs that inhibit CYP450 enzymes, is at risk of a toxic accumulation of the drug leading to more severe side effects.

There does not appear to be any scientific data about exactly why suicidality and behavior changes are potential adverse reactions, but we might surmise that messing with hormones in the brain is not exactly a well-known precision science.

The major issue we see is that mood changes as a side effect from Orilissa are likely to be misdiagnosed. Since psychiatrists do not perform clinical tests and are wont to prescribe an antidepressant rather than get to the root of the problem, we want to be sure every candidate for this drug understands the issue and practices full informed consent to any psychiatric treatment.

1 in 4 Elderly Americans Hooked on Xanax

Saturday, February 9th, 2019

One in four older Americans who use prescribed benzodiazepine drugs such as Xanax (generic alprazolam) for sleep issues, anxiety and depression end up becoming addicted, according to a recent study.

The study, published 10 September 2018 in JAMA Internal Medicine, found that for every 10 additional days of prescribed drugs, the patient’s risk for long-term usage nearly doubled over the next year.
[doi:10.1001/jamainternmed.2018.2413]

This abusive assault on the elderly is the result of psychiatry maneuvering itself into an authoritative position over aged care. From there, psychiatry has broadly perpetrated the tragic but lucrative hoax that aging is a mental disorder requiring extensive and expensive psychiatric services.

Long-term benzodiazepine users are more likely to develop anxiety or have sleep problems, the very things the drug was supposed to treat. The FDA recommends reporting adverse psychiatric drug reactions to the MedWatch program. It could be dangerous to immediately cease taking psychiatric drugs because of potential significant withdrawal side effects. No one should stop taking any psychiatric drug without the advice and assistance of a competent medical doctor.

The exact mechanism of action of benzodiazepines is not known, but they play Russian Roulette with neurotransmitters in the brain.

Daily use of benzodiazepines has always been associated with physical dependence. Addiction can occur after just 14 days of regular use. Withdrawal and addiction to benzodiazepines can be as traumatic as with heroin.

The typical consequences of withdrawal are anxiety, depression, sweating, cramps, nausea, psychotic reactions and seizures. There is also a “rebound effect” where the individual experiences even worse symptoms than they started with as a result of this chemical dependency.

Xanax is particularly obnoxious. After a patient stops taking Xanax, it takes the brain six to eighteen months to recover. Extreme anger, hostile behavior, violence and suicide are potential side effects.

Once they are taking the drug and have side effects they can be diagnosed with a fraudulent mental illness called “Sedative-, hypnotic-, or anxiolytic-induced anxiety disorder” and prescribed additional psychiatric drugs for the side effects. [Anxiolytic just means anti-anxiety drug.]

Then, once they are addicted and try to withdraw from the drug, they can be diagnosed with a fraudulent mental illness called “Sedative, hypnotic, or anxiolytic withdrawal” and prescribed additional psychiatric drugs for the withdrawal symptoms.

The real problem is that psychiatrists fraudulently diagnose life’s problems as an “illness”, and stigmatize unwanted behavior as  “diseases.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax – unscientific, fraudulent and harmful.

CCHR recommends that everyone watch the video documentary “Making A Killing – The Untold Story of Psychotropic Drugging“. Containing more than 175 interviews with lawyers, mental health experts, the families of psychiatric abuse victims and the survivors themselves, this riveting documentary rips the mask off psychotropic drugging and exposes a brutal but well-entrenched money-making machine. The facts are hard to believe, but fatal to ignore. Watch the video online here.